Bone secondary localizations from metastatic castration-resistant prostate cancer are associated with an increase in mortality and a reduction in the patient's quality of life. Radium-223 is a targeted alpha-therapy approved for the treatment of mCRPC (metastatic castration resistant prostate cancer) patients with symptomatic bone metastases. To our knowledge, no previous study has been performed assessing the bone pain palliation outcomes following Radium-223 therapy.

Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC / Frantellizzi, Viviana; Lazri, Julia; Pontico, Mariano; Pani, Arianna; De Vincentis, Giuseppe. - In: ARCHIVIO ITALIANO DI UROLOGIA ANDROLOGIA. - ISSN 2282-4197. - 92:3(2020), pp. 1-4. [10.4081/aiua.2020.3.196]

Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC

Frantellizzi, Viviana
Primo
;
Lazri, Julia
Secondo
;
Pontico, Mariano;De Vincentis, Giuseppe
Ultimo
2020

Abstract

Bone secondary localizations from metastatic castration-resistant prostate cancer are associated with an increase in mortality and a reduction in the patient's quality of life. Radium-223 is a targeted alpha-therapy approved for the treatment of mCRPC (metastatic castration resistant prostate cancer) patients with symptomatic bone metastases. To our knowledge, no previous study has been performed assessing the bone pain palliation outcomes following Radium-223 therapy.
2020
radium-223 dichloride; bone pain; palliative treatment; mCRPC
01 Pubblicazione su rivista::01i Case report
Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC / Frantellizzi, Viviana; Lazri, Julia; Pontico, Mariano; Pani, Arianna; De Vincentis, Giuseppe. - In: ARCHIVIO ITALIANO DI UROLOGIA ANDROLOGIA. - ISSN 2282-4197. - 92:3(2020), pp. 1-4. [10.4081/aiua.2020.3.196]
File allegati a questo prodotto
File Dimensione Formato  
Frantellizzi_Bone-pain_2020.pdf

accesso aperto

Note: https://pagepressjournals.org/index.php/aiua/article/view/aiua.2020.3.196
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 434.37 kB
Formato Adobe PDF
434.37 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1441881
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact